Considerations for a successful tech transfer of a biologics upstream process
Bioprocess experts from Lonza discuss how molecular format and the product lifecycle phase impact the process, risks and outcomes of upstream technology transfer of biologics.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
